Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Opsonin receptors are a functional class of leukocyte surface proteins that recognize and bind to opsonins, which are host-derived molecules like antibodies (IgG) and complement fragments (C3b, iC3b) that coat pathogens or apoptotic cells. This group primarily includes Fc receptors (FcRs) and complement receptors (CRs), such as CR1, CR3 (Mac-1), and CR4, which are expressed on neutrophils, macrophages, and other myeloid cells. Upon ligation with opsonized targets, these receptors initiate intracellular signaling cascades—often involving Src-family kinases and Syk—that lead to phagocytosis, the release of reactive oxygen species, and the secretion of inflammatory cytokines. They are essential for the clearance of infectious agents and the maintenance of immune homeostasis, but their dysregulation is a key driver in autoimmune diseases and chronic inflammatory conditions. Therapeutic modulation of these receptors includes the use of intravenous immunoglobulin (IVIG) to block Fc receptors or monoclonal antibodies designed to enhance or inhibit opsonin-mediated cell clearance in cancer and inflammatory disorders.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opsonin receptors.